Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Comment by cleareyeon Sep 03, 2020 10:16am
130 Views
Post# 31501043

RE:Year End Estimates?

RE:Year End Estimates?I think that the covid19 pandemic caused them considerable pain in their core business and their initial thoughts of getting into the business of a covid19 therapy caused them further pain with shareholders.

Otherwise their core business continues to grow. I don't know what their results will be to year end, but I do believe that we will see a steady growth in their core business. By the end of the calendar year (not the fiscal year) I think that they should be able to show quarters where they are turning a profit.

Until then, we may very well see people exiting in the next few weeks and then a more stable, but low, share price.

Genuinely sorry for the loss that some have incurred here. I too have lost.

cleareye.
<< Previous
Bullboard Posts
Next >>